- Product NDC
- 55714-4848
- 11-digit product format
- 557144848
- Labeler code
- 55714
- Product ID
- 55714-4848_fb45e5e2-93c8-da49-e053-6294a90a35d1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Ruta graveolens, Valeriana officinalis, Adrenalinum, Arsenicum iodatum, Aurum metallicum, Baryta carbonica, Bryonia, Cactus grandiflorus, Chelidonium majus, Cinchona officinalis, Crotalus horridus, Digitalis purpurea, Glonoinum, Kali carbonicum, Kali iodatum, Lachesis mutus, Naja tripudians, Nux vomica, Veratrum album, Vipera berus, Viscum album, Elaps corallinus.
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Newton Laboratories, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2023-05-09
- Substance
- ARSENIC TRIIODIDE; BARIUM CARBONATE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; EPINEPHRINE; GOLD; LACHESIS MUTA VENOM; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; NITROGLYCERIN; POTASSIUM CARBONATE; POTASSIUM IODIDE; RUTA GRAVEOLENS FLOWERING TOP; SELENICEREUS GRANDIFLORUS STEM; STRYCHNOS NUX-VOMICA SEED; VALERIAN; VERATRUM ALBUM ROOT; VIPERA BERUS VENOM; VISCUM ALBUM FRUITING TOP
- Active strength
- 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 6; 15; 15; 6; 15; 16; 15 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes